본문 바로가기
KERD
논문KCI 등재

Optimization of Allergen Standardization

2

조회

0

다운로드

15

인용

0

참고문헌

키워드

주제분류의학일반

초록

Preparation of high quality allergen extracts is essential for the diagnosis and immunotherapy of allergic disorders. Standardization of allergen extracts concerns determination of the allergen unit, development of reference material and measurement of the overall IgE binding capacity of an allergen extract. Recently, quantification of individual allergens has been the main focus of allergen standardization because the allergenicity of most allergen extracts is known to be mainly dependent on the content of a small number of allergen molecules. Therefore, characterization of major allergens will facilitate the standardization of allergens. In this article, we review the current state of allergen standardization. In addition, we briefly summarize the components of allergen extracts that should be under control for the optimization of allergen standardization, since its adjuvant-like activities could play an important role in allergic reactions even though the molecule itself does not bind to the IgE antibodies from subjects.

Abstract

Preparation of high quality allergen extracts is essential for the diagnosis and immunotherapy of allergic disorders. Standardization of allergen extracts concerns determination of the allergen unit, development of reference material and measurement of the overall IgE binding capacity of an allergen extract. Recently, quantification of individual allergens has been the main focus of allergen standardization because the allergenicity of most allergen extracts is known to be mainly dependent on the content of a small number of allergen molecules. Therefore, characterization of major allergens will facilitate the standardization of allergens. In this article, we review the current state of allergen standardization. In addition, we briefly summarize the components of allergen extracts that should be under control for the optimization of allergen standardization, since its adjuvant-like activities could play an important role in allergic reactions even though the molecule itself does not bind to the IgE antibodies from subjects.

참고문헌 (85)

  1. Noon L, "Prophylactic inoculation against hay fever", Lancet, 1, pp.1572~1573 (1911)
  2. Freeman J, "Further observation on the treatment of hay-fever by hypodermic inoculation of pollen vaccine", Lancet, 2, pp.814~817 (1911)
  3. Patterson ML, "Characterization and comparison of commercially available German and American cockroach allergen extracts", Clin Exp Allergy, 32, pp.721~727 (2002)
  4. Larenas-Linnemann D, "European allergen extract units and potency: review of available information", Ann Allergy Asthma Immunol, 100, pp.137~145 (2008)
  5. Brunetto B, "Characterization and comparison of commercially available mite extracts for in vivo diagnosis", Allergy, 65, pp.184~190 (2010)
  6. Rossi R, "The biological potency of different extracts for sublingual immunotherapy assessed by skin prick tests", Eur Ann Allergy Clin Immunol, 42, pp.112~114 (2010)
  7. Morrow KS, "Regulatory aspects of allergen vaccines in the US", Clin Rev Allergy Immunol, 21, pp.141~152 (2001)
  8. Larsen JN, "Standardization of allergen extracts", Methods Mol Med, 138, pp.133~145 (2008)
  9. Burazer L, "Impact of Dermatophagoides pteronyssinus mite body raw material on house dust mite allergy diagnosis in a Serbian population", Med Vet Entomol, 25, pp.77~83 (2011)
  10. Weghofer M, "Variability of IgE reactivity profiles among European mite allergic patients", Eur J Clin Invest, 38, pp.959~965 (2008)
  11. May JC, "Optimization of parameters in protein nitrogen unit precipitation procedure for allergenic extracts", J Allergy Clin Immunol, 63, pp.87~97 (1979)
  12. Dreborg S, "Precision of biological standardization of allergenic preparations", Allergy, 47, pp.291~294 (1992)
  13. Turkeltaub PC, "A standardized quantitative skin-test assay of allergen potency and stability: studies on the allergen dose-response curve and effect of wheal, erythema, and patient selection on assay results", J Allergy Clin Immunol, 70, pp.343~352 (1982)
  14. Ibarrola I, "Biological characterization of glutaraldehyde-modified Parietaria judaica pollen extracts", Clin Exp Allergy, 34, pp.303~309 (2004)
  15. Grier TJ, "Laboratory methods for allergen extract analysis and quality control", Clin Rev Allergy Immunol, 21, pp.111~140 (2001)
  16. Kleine Budde I, "The stripped basophil histamine release bioassay as a tool for the detection of allergen-specific IgE in serum", Int Arch Allergy Immunol, 126, pp.277~285 (2001)
  17. Kaul S, "Mediator release assays based on human or murine immunoglobulin E in allergen standardization", Clin Exp Allergy, 37, pp.141~150 (2007)
  18. Ferreira F, "Modified recombinant allergens for safer immunotherapy", Inflamm Allergy Drug Targets, 5, pp.5~14 (2006)
  19. Jeong KY, "Recombinant allergens for diagnosis and immunotherapy of allergic disorders, with emphasis on cockroach allergy", CURRENT PROTEIN & PEPTIDE SCIENCE, 7, pp.57~71 (2006)
  20. Dreborg S, "The major allergen content of allergenic preparations reflect their biological activity", Allergy, 47, pp.418~423 (1992)
  21. van Ree R, "Indoor allergens: relevance of major allergen measurements and standardization", J Allergy Clin Immunol, 119, pp.270~277 (2007)
  22. Jutel M, "Allergen-specific immunotherapy with recombinant grass pollen allergens", J Allergy Clin Immunol, 116, pp.608~613 (2005)
  23. Creticos PS, "Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis", N Engl J Med, 355, pp.1445~1455 (2006)
  24. van Ree R, "Allergy vaccines: a need for standardisation in mass units of major allergen", Pharmeuropa Bio, 2005, pp.27~30 (2005)
  25. van Ree R, "The CREATE project: EU support for the improvement of allergen standardization in Europe", Allergy, 59, pp.571~574 (2004)
  26. King TP, "Allergen nomenclature. WHO", IUIS Allergen Nomenclature Subcommittee, 1994, pp.105, 224~233
  27. van Ree R, "Analytic aspects of the standardization of allergenic extracts", Allergy, 52, pp.795~805 (1997)
  28. Jeong KY, "Sequence diversity of the Bla g 4 cockroach allergen, homologous to lipocalins, from Blattella germanica", International Archives Of Allergy And Immunology, 148(4), pp.339~345 (2009)
  29. Smith WA, "Allergens of wild house dust mites: environmental Der p 1 and Der p 2 sequence polymorphisms", J Allergy Clin Immunol, 107, pp.985~992 (2001)
  30. Piboonpocanun S, "Genetic polymorphisms of major house dust mite allergens", Clin Exp Allergy, 36, pp.510~516 (2006)
  31. Ferreira F, "Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy", J Exp Med, 183, pp.599~609 (1996)
  32. Arquint O, "Reduced in vivo allergenicity of Bet v 1d isoform, a natural component of birch pollen", J Allergy Clin Immunol, 104, pp.1239~1243 (1999)
  33. Reyes-López CA, "A single amino acid substitution on the surface of a natural hevein isoform (Hev b 6.0202), confers different IgE recognition", FEBS Lett, 580, pp.2483~2487 (2006)
  34. Park JW, "Der p 2 isoallergens have different allergenicity, and quantification with 2-site ELISA using monoclonal antibodies is influenced by the isoallergens", Clin Exp Allergy, 32, pp.1042~1047 (2002)
  35. Jeong KY, "Monoclonal antibodies to recombinant Der f 2 and development of a two-site ELISA sensitive to major Der f 2 isoallergen in Korea", Allergy, 57, pp.29~34 (2002)
  36. Grier TJ, "Major allergen measurements: sources of variability, validation, quality assurance, and utility for laboratories, manufacturers, and clinics", Allergy Asthma Proc, 23, pp.125~131 (2002)
  37. Løwenstein H, "The significance of isoallergenic variations in present and future specific immunotherapy", Int Arch Allergy Immunol, 107, pp.285~289 (1995)
  38. Jacquet A, "The Role of the House Dust Mite-Induced Innate Immunity in Development of Allergic Response", Int Arch Allergy Immunol, 155, pp.95~105 (2010)
  39. Osterlund C, "Non-Proteolytic Aeroallergens from Mites, Cat and Dog Exert Adjuvant-Like Activation of Bronchial Epithelial Cells", Int Arch Allergy Immunol, 155, pp.111~118 (2010)
  40. Willart MA, "The danger within: endogenous danger signals, atopy and asthma", Clin Exp Allergy, 39, pp.12~19 (2009)
  41. Liu AH, "Endotoxin exposure in allergy and asthma: reconciling a paradox", J Allergy Clin Immunol, 109, pp.379~392 (2002)
  42. Michel O, "Role of lipopolysaccharide (LPS) in asthma and other pulmonary conditions", J Endotoxin Res, 9, pp.293~300 (2003)
  43. Trompette A, "Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein", Nature, 457, pp.585~588 (2009)
  44. Doreswamy V, "Modulation of asthma by endotoxin", Clin Exp Allergy, 41, pp.9~19 (2011)
  45. Tulic MK, "Role of toll-like receptor 4 in protection by bacterial lipopolysaccharide in the nasal mucosa of atopic children but not adults", Lancet, 363, pp.1689~1697 (2004)
  46. Rylander R, "(1→3)-beta-D-glucan and endotoxin modulate immune response to inhaled allergen", Mediators Inflamm, 7, pp.105~110 (1998)
  47. Thorn J, "Airways inflammation and glucan in a rowhouse area", Am J Respir Crit Care Med, 157, pp.1798~1803 (1998)
  48. Finkelman MA, "β-Glucans in standardized allergen extracts", J Endotoxin Res, 12, pp.241~245 (2006)
  49. Simonen-Jokinen T, "Direct activation of gelatinase B (MMP-9) by hay dust suspension and different components of organic dust", Vet Immunol Immunopathol, 109, pp.289~295 (2006)
  50. 정경용, "Enzymatic Activities of Allergen Extracts from Three Species of Dust Mites and Cockroaches Commonly Found in Korean Home", The Korean Journal of Parasitology, 48(2), pp.151~155 (2010), 대한기생충학회
  51. Thomas WR, "Pyroglyphid house dust mite allergens", Protein Pept Lett, 14, pp.943~953 (2007)
  52. Hewitt CR, "A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: innate protection by antiproteases", J Exp Med, 182, pp.1537~1544 (1995)
  53. Ghaemmaghami AM, "cell subset commitment determined by the intrinsic property of antigen: the proteolytic activity of the major mite allergen Der p 1 conditions T cells to produce more IL-4 and less IFN-gamma", Eur J Immunol, 31, pp.1211~1216 (2001)
  54. Smith PK, "Serine proteases, their inhibitors and allergy", Allergy, 61, pp.1441~1447 (2006)
  55. Chapman MD, "Proteases as Th2 adjuvants", Curr Allergy Asthma Rep, 7, pp.363~367 (2007)
  56. Gough L, "The cysteine protease activity of the major dust mite allergen Der p 1 selectively enhances the immunoglobulin E antibody response", J Exp Med, 190, pp.1897~1902 (1999)
  57. Gough L, "The proteolytic activity of the major dust mite allergen Der p 1 enhances the IgE antibody response to a bystander antigen", Clin Exp Allergy, 31, pp.1594~1598 (2001)
  58. Nagata S, "Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation", J Allergy Clin Immunol, 80, pp.24~32 (1987)
  59. Maruo K, "Generation of anaphylatoxins through proteolytic processing of C3 and C5 by house dust mite protease", J Allergy Clin Immunol, 100, pp.253~260 (1997)
  60. Karp CL, "Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma", Nat Immunol, 1, pp.221~226 (2000)
  61. Asokananthan N, "Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells", J Immunol, 168, pp.3577~3585 (2002)
  62. Miike S, "Human eosinophils are activated by cysteine proteases and release inflammatory mediators", J Allergy Clin Immunol, 111, pp.704~713 (2003)
  63. Sokol CL, "A mechanism for the initiation of allergen-induced T helper type 2 responses", Nat Immunol, 9, pp.310~318 (2008)
  64. Kato T, "Cystatin A inhibits IL-8 production by keratinocytes stimulated with Der p 1 and Der f 1: biochemical skin barrier against mite cysteine proteases", J Allergy Clin Immunol, 116, pp.169~176 (2005)
  65. Ribas A, "Protozoal forms in house-dust mites and respiratory allergy", Allergy Asthma Proc, 27, pp.347~349 (2006)
  66. Martínez-Girón R, "Flagellated protozoa in cockroaches and sputum: the unhygienic connection", Allergy Asthma Proc, 28, pp.608~609 (2007)
  67. Yao G, "Bronchopulmonary infection with Lophomonas blattarum: two cases report and literature review", J Med Coll PLA, 23, pp.176~182 (2008)
  68. Martínez-Girón R, "Is the dust mite allergen Der p1 protozoal in origin", Scand J Immunol, 70, pp.75~76 (2009)
  69. Peregrine PC, "Host dietary changes and the hindgut fauna of cockroaches", Int J Parasitol, 4, pp.645~656 (1974)
  70. Im J, "Induction of IL-8 expression by bacterial flagellin is mediated through lipid raft formation and intracellular TLR5 activation in A549 cells", MOLECULAR IMMUNOLOGY, 47(2-3), pp.614~622 (2009), PERGAMON-ELSEVIER SCIENCE LTD
  71. Le TA, "Flagellin Induces the Expression of Thymic Stromal Lymphopoietin in Human Keratinocytes via Toll-Like Receptor 5", Int Arch Allergy Immunol, 155, pp.31~37 (2010)
  72. Zhu Z, "Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation", Science, 304, pp.1678~1682 (2004)
  73. Elias JA, "Chitinases and chitinase-like proteins in T(H)2 inflammation and asthma", J Allergy Clin Immunol, 116, pp.497~500 (2005)
  74. Schubert MS, "A superantigen hypothesis for the pathogenesis of chronic hypertrophic rhinosinusitis, allergic fungal sinusitis, and related disorders", Ann Allergy Asthma Immunol, 87, pp.181~188 (2001)
  75. Hochrein H, "Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways", Proc Natl Acad Sci U S A, 101, pp.11416~11421 (2004)
  76. Lazarczyk M, "Immunostimulatory oligonucleotides in therapy of allergic diseases", Expert Opin Biol Ther, 5, pp.525~536 (2005)
  77. Valerio CR, "Bacterial 16S ribosomal DNA in house dust mite cultures", J Allergy Clin Immunol, 116, pp.1296~1300 (2005)
  78. Huffnagle GB, "The microbiota and allergies", asthma, 2010, pp.6, e1000549~
  79. Huang YJ, "Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma", J Allergy Clin Immunol, 127, pp.372~381 (2011)
  80. Jackson DJ, "The role of viruses in acute exacerbations of asthma", J Allergy Clin Immunol, 125, pp.1178~1187 (2010)
  81. Park JW, "Identification and characterization of the major allergen of the Humulus japonicus pollen", Clin Exp Allergy, 29, pp.1080~1086 (1999)
  82. Kim YK, "Spider-mite allergy and asthma in fruit growers", Curr Opin Allergy Clin Immunol, 2, pp.103~107 (2002)
  83. Jeong KY, "Molecular cloning and characterization of tropomyosin, a major allergen of Chironomus kiiensis, a dominant species of nonbiting midges in Korea", CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 11(2), pp.320~324 (2004), AMER SOC MICROBIOLOGY
  84. Kim CW, "Respiratory allergy to the indoor ant (Monomorium pharaonis) not related to sting allergy", ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 94, pp.301~306 (2005)
  85. Yun YY, "Anaphylaxis to venom of the Pachycondyla species ant", J Allergy Clin Immunol, 104, pp.879~882 (1999)

관련 논문AI추천

이 간행물의 다른 논문 (13건)